Consolidated Balance Sheets - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Current assets: |
|
|
| Cash and cash equivalents |
$ 90,765
|
$ 116,737
|
| Prepaid and other |
2,088
|
1,266
|
| Total current assets |
92,853
|
118,003
|
| Right-of-use asset |
75
|
40
|
| Other assets |
657
|
766
|
| Total assets |
93,585
|
118,809
|
| Current liabilities: |
|
|
| Accounts payable |
1,959
|
1,143
|
| Accrued liabilities |
3,431
|
3,042
|
| Deferred grant revenue |
1,600
|
1,633
|
| Lease, current |
75
|
40
|
| Total current liabilities |
5,465
|
5,858
|
| Commitments and contingencies (Note 3) |
|
|
| Stockholders’ equity: |
|
|
| Preferred stock, $0.001 par value, authorized shares – 5,000 at December 31, 2021 and 2020; issued and outstanding shares – none |
|
|
| Common stock, $0.001 par value; authorized shares – 120,000 at December 31, 2021 and 60,000 at 2020; issued and outstanding shares – 49,429 and 48,802 at December 31, 2021 and 2020, respectively |
49
|
49
|
| Additional paid-in capital |
202,201
|
195,699
|
| Accumulated deficit |
(114,130)
|
(82,797)
|
| Total stockholders’ equity |
88,120
|
112,951
|
| Total liabilities and stockholders’ equity |
$ 93,585
|
$ 118,809
|